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The Effect of Childhood-versus Adult-Onset Obesity on Cardiorespiratory Fitness, 
Handgrip Strength, Resting Metabolic Rate and Substrate Oxidation in Adults 
Dera A, Santosa S: Concordia University, Montreal, QC 
 
BACKGROUND: Obesity is associated with a variety of cardiovascular, pulmonary, and 
skeletal muscle aberrations that negatively affect physical fitness and other metabolic 
parameters. However, it is unclear whether these impairments are exacerbated in lifelong 
obesity. OBJECTIVE: We aimed to examine how age of obesity onset (childhood versus adult) 
affects cardiorespiratory fitness (CRF), handgrip strength, resting metabolic rate (RMR), and 
substrate oxidation in adults. METHODS: We recruited 31 adults (BMI 29.5 to 39.4 kg/m2) who 
had either developed obesity before puberty (childhood-onset [CO]; n=13) or after the age of 18 
(adult-onset [AO]; n=18). CRF was measured using the YMCA submaximal bike test and 
handgrip strength was measured using handgrip dynamometry. RMR and substrate oxidation was 
measured using indirect calorimetry. RESULTS: Mean handgrip strength (±SD) was lower in 
adults with childhood- versus adult-onset obesity (CO: 56 ± 10 vs. AO: 72 ± 20 kg; p = 0.01). 
Fat oxidation was also lower in the childhood-onset group (CO: 51.07 ± 18.39 vs. AO: 67.55 ± 
23.83 mg/min; p = 0.04), while CRF, RMR and carbohydrate oxidation were not different 
between groups (p > 0.05). These results persisted when adjusting for age, sex, and body 
composition. CONCLUSION: Our results show that persistent obesity since childhood impairs 
muscle strength and fat oxidation, but not RMR and CRF, compared to adult-onset obesity. 
These results suggest that maintaining a healthy body weight early in life may delay the loss of 
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Background and literature review 
1. Introduction 
Obesity is defined as an excessive accumulation of body fat that negatively impacts 
health1. Operationally, the World Health Organization (WHO) defines obesity as a body mass 
index (BMI) of greater than or equal to 30 kg/m21. In Canada, obesity in the adult population 
(aged ≥18) has increased steadily from 6.1% in 1985 to 18.1% in 20112. It is estimated that 
obesity prevalence in Canadian adults will increase to 21.2% by 2019, causing an annual 
economic burden between $4.6 and $7.1 billion3. Obesity is linked to an increased risk of 
developing chronic diseases, such as cardiovascular disease (CVD), type 2 diabetes, and 
stroke4,5. Furthermore, obesity has been associated with increased incidences of breast, colon, 
and prostate cancer among other co-morbidities6. However, not all individuals with obesity have 
the same disease risk profile. One factor that might explain this variability is the age at which an 
individual develops obesity. Numerous studies have shown that adults with childhood-onset 
obesity have higher risk of various chronic illnesses in adulthood, including cardiovascular, 
musculoskeletal and metabolic diseases, compared to those with adult-onset obesity 7-11. Given 
that higher CRF and muscle strength are associated with reduced comorbidities in obesity, it is 
possible that there are differences in these fitness components, as well as other metabolic factors, 
in individuals with childhood-onset and adult-onset obesity12-14,15. At the present time, there are 
limited data available regarding the impact and implications of the timing of obesity onset on 
cardiorespiratory fitness (CRF), skeletal muscle strength, resting metabolic rate (RMR) and 
substrate oxidation.  
 
2. The significance of age of obesity onset 
Children who develop obesity under the age of eight and continue to have obesity 
throughout adulthood are at an increased risk of developing CVD, type 2 diabetes, 
musculoskeletal disorders, and cancer (Figure 1)7. Longitudinal studies that have tracked cohorts 
of children into adulthood observed that not only is overweight/obesity in childhood a risk factor 
for adulthood overweight/obesity, but is also associated with higher rates of morbidity and 
mortality10,16,17. One explanation for the observed discrepancy in disease risk between childhood-
onset and adult-onset obesity arises from known differences in adipose tissue form and function. 
Age of obesity onset affects the number and size of adipocytes in obese and overweight 
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adults18,19. Adults who developed obesity in childhood increase their adipose tissue by 
hyperplasia (increased number) and /or hypertrophy (increased size). However, adults who 
develop obesity later in life increase adipose tissue by hypertrophy19. A study conducted by 
Brook et al18 investigated the relationship between age of obesity onset and number of 
adipocytes. The total number of adipocytes was significantly increased in children who had 
obesity by the age of one year, as well as in adults who dated their obesity to childhood. A recent 
study showed that the number of adipocytes increases in childhood and adolescence, while the 
number remains constant in adulthood in both lean and obese individuals19. Both hyperplasia 
(number) and hypertrophy (size) contribute to adipose tissue remodeling19. In the obese state, 
adipose tissue remodeling is associated with many metabolic disease risk factors such as cell 
death, inflammation, altered adipokine profile, and hypoxia20. Furthermore, another study found 
a strong association between increased adipocyte size and insulin resistance that was already 
apparent in childhood21.  
Apart from differences in adipocytes, several studies found that obese children and adults 
had higher resting cardiac output and stroke volume, causing significant stress to the 
cardiovascular system22. This eventually leads to functional and structural changes in the 
heart23,24, especially in individuals with a BMI above 40 kg/m2 who had obesity for more than 10 
years25. In addition, childhood obesity is associated with left ventricular hypertrophy, elevated 
levels of C-reactive protein and other risk factors for coronary heart disease (CHD)26. In 
summary, certain changes in the heart and adiposity during growth can work together to impact 
health status in childhood and adolescence, and potentially influence future disease risk in 














 Figure1. Schematic diagram summarizing the complications of childhood obesity (adapted and 
redrawn from Lakshman) 7. 
 
3. Cardiorespiratory fitness 
Cardiorespiratory fitness (CRF) is a health-related component of physical fitness and an 
important marker of cardiovascular health27,28. CRF can be defined as the ability of the 
circulatory and respiratory systems to deliver oxygen to the muscular system, and for the 
muscles to efficiently utilize oxygen during sustained physical activity29,30. CRF can be 
expressed in metabolic equivalents (METs) or maximal oxygen uptake (VO2max) and measured 
as an absolute value or scaled to an individual on the basis of body weight29,31. The latter 
approach may be more appropriate, as it gives the ability to compare people with different sizes 
and allows for safer exercise prescription in individuals with obesity32-34. Several studies found 
that doing the equivalent amount of absolute work is not the same in terms of the oxygen 
consumption for individuals with obesity compared to normal weight population, especially with 
weight bearing activity33,35,36. A study by Mattson et al33 found that normal-weight individuals 
had lower relative oxygen costs (36% of VO2max) when compared to individuals with obesity 



















It is well known that obesity and low CRF are associated with high risk of CVD and all-
cause mortality14. In general, studies have shown that individuals with obesity have reduced 
CRF37,38. However, the risk of mortality and morbidity have been found to be reduced by higher 
CRF regardless of whether an individual is of normal weight or has overweight or obesity12-14. In 
addition, a meta-analysis found that a 1 MET (3.5 ml·kg-1·min-1 ) improvement in CRF equates 
to a 13% and 15% decrease in all-cause mortality and cardiovascular events, respectively28. 
Furthermore, increased CRF helps improve muscle insulin sensitivity, which facilitates the 
transport of glucose from blood to muscle39. It can also increase lipoprotein lipase activity in 
skeletal muscle which can in turn, improve clearance rates of plasma triglycerides and increase 
transport of lipids and lipoproteins from the peripheral circulation and tissues to the liver40 
 
3.1 Factors limiting VO2max consumption  
 VO2max can be limited through three primary physiological factors: 1) the pulmonary 
diffusing capacity, 2) cardiac output, and 3) blood volume and flow41.  
            Pulmonary diffusing capacity is defined as the ability to transfer (diffuse) oxygen and 
carbon dioxide between the lungs and the blood. Pulmonary diffusion may become a limiting 
factor when a high increase in cardiac output shortens the time during which the blood can take 
the oxygen from  the lungs, possibly leading to lower blood oxygen saturation levels42,43. 
  Cardiac output is the amount of blood pumped by each ventricle in one minute; it is the 
stroke volume multiplied by heart rate (HR)44. Therefore, an increase in either HR or stroke 
volume increases cardiac output. Cardiac output normally ranges from 4.5 to 5.5 L/min in adults 
in the resting state and can increase up to 20-30 L/min during maximal exertion44. 
Stroke volume is the amount of blood pumped in one beat. Stroke volume is the product 
of end of diastolic volume subtracted from the end systolic volume, which is the blood that 
remains in the ventricle after contraction. There are three factors that effect stroke volume: 
contractility, preload, and afterload. Contractility is defined by the force of the contraction of the 
heart muscle. Preload is the stretch of the left ventricle of the heart to allow for blood filling and 
can be measured by the end diastolic volume. Then, afterload is the pressure that the ventricle 
needs to overcome to eject blood. However, not all blood is ejected from the ventricle in each 




With regard to blood volume and flow, we know that the working muscle needs more 
oxygen and nutrients than other muscle. Enhanced blood flow achieved by reducing blood’s 
viscosity, can overcome this limitation and improve oxygen delivery to the working muscle45.  
  
3.2 Measurement of cardiorespiratory fitness   
The VO2max test, the direct measurement of maximal oxygen consumption, is considered 
the gold standard for assessing CRF29,46-48. Limitations of using the VO2max method include 
cost, need for highly trained personnel, specialized equipment49. In comparison, submaximal 
testing provides an alternative for assessing CRF in obese or otherwise unhealthy 
individuals33,34,48. Various submaximal tests have been developed to assess CRF, including the 
Astrand-Rhyming test50, Canadian aerobic fitness test51, YMCA cycle ergometer test52, and a 
single-stage submaximal treadmill walking test53. 
The YMCA test is a commonly used submaximal fitness test with a multistage protocol 
that progressively increases the workload based on the participant’s heart rate52,54. A study by 
Carter et al55 compared the treadmill VO2max test to the submaximal YMCA protocol and found 
that the YMCA test underestimated VO2max by approximately 5-10%. This might be due to 
different factors including reduced muscle mass engagement and biomechanical inefficiencies 
during cycling. As the protocol relies on the relationship between heart rate and oxygen 
consumption, decreased biomechanical efficiency may result in an under-prediction of aerobic 
capacity54. However, previous research has confirmed the validity of using the submaximal cycle 
ergometer test to predict VO2max. A study by George et al
56 compared the cycle ergometer test 
to the maximal graded exercise test on a treadmill for assessing VO2max using a larger sample 
size (n=156). The VO2max results derived from both these tests showed a significant positive 
relationship in women (r = 0.90) and men (r = 0.74). Selected participants in this study (n=34) 
performed the submaximal test twice over a 5-day period to confirm intra-class reliability (r = 
0.93). These results were supported in a separate cross-validation study by Beekley et al52. This 
study found no statistically significant difference between the YMCA predicted VO2max and the 
standard measure of VO2max (mean difference = 1.3 ml·kg
-1·min-1), suggesting that the YMCA 
stationary bike test is effective in predicting VO2max. These results were further supported by a 




 3.3 Implications of obesity on cardiorespiratory fitness 
The increased mass of adipose tissue in obesity could affect CRF by putting stress on the 
heart and increasing the overall metabolic demand of the body25. This can also lead to a larger 
blood volume and resulting increases in left ventricle preload and afterload which in turn, can 
cause left ventricular hypertrophy22,57. Abnormalities in left ventricular diastolic filling have 
been found in 50% of individuals with obesity57. Abnormal myocardial function during exercise 
is evidenced by a decrease in stroke volume, lower maximal cardiac output as well as a decrease 
in other markers of diastolic and systolic function58. Studies show that individuals with obesity 
demonstrate suppression of ventricular function at rest and decrease of myocardial performance 
during exercise59-61. A study by Alpert et al62 illustrated that during exercise alterations in left 
ventricle ejection fraction were more related to heart mass in individuals with class III obesity 
BMI (> 40 kg/m2). In individuals with a heart mass around 150-200 grams, a normal response 
was observed (+20-30%), whereas in individual with a heart mass > 350 grams, the ejection 
fraction fell with exercise. Furthermore, Licata et al63 found that percent change in ejection 
fraction at peak exercise negatively correlated with the duration of obesity (r =-0.59).  Ejection 
fraction was only increased in individuals who had obesity for less than 10 years.  
With respect to performance-based CRF, obesity has been shown to be detrimental. A 
study conducted by Drinkard et al64 observed a negative correlation (r = - 0.82) between the BMI 
and distance on a 12-minute walk/run test. A separate study conducted by Rowland et al65 
concluded that the increased effort required by individuals with obesity to move their additional 
body mass may explain 32% of the variance in finishing times during a one-mile run.  
  Studies in adults and children consistently find that VO2max, a marker of CRF, is lower 
in obese compared to lean individuals37,66,67. Despite studies that show greater CRF in people 
with obesity (expressed in L/min), when adjustment for weight is made, the opposite is true68. A 
study by Hulens et al36 found that obese subjects had lower VO2max compared to lean subjects 
(12.3 ± 1.8 ml·kg-1·min-1 and 17.7 ± 2.4 ml·kg-1·min-1, respectively). Another study by Vinet et 
al69 that compared two groups of men, obese adult to normal weight, also found that the obese 
group had a significantly lower mean VO2max (27.9 ± 1.7 ml·kg
-1·min-1)vs 38.6 ± 1.2 ml·kg-
1·min-1). Loftin et al70 reported that the average VO2max for preadolescent girls with normal 
weight was significantly higher (45.8 ± 7.2 ml·kg-1·min-1) compared to preadolescent girls with 
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obesity (22.8 ± 7.3 ml/kg/min). Thus, lower CRF in individuals with obesity is more likely due 
to a higher body weight that inflates the size-normalizing factor (‘per kg’). 
Despite the well-documented effects of obesity on CRF, there is limited data available 
that specifically identifies the effects of age of obesity onset. To our knowledge, only a single 
study by Rupp et al71, has examined this relationship. In their study, there were differences 
between groups with childhood-onset obesity and adult-onset obesity. The childhood-onset 
group had significantly higher CRF. However, limitations of this study include a wide BMI 
range (25-40 kg/m2), a retrospective classification of participants into the childhood-onset and 
adult-onset groups, and differences in age between the two groups; the childhood-onset group 
was significantly younger. Therefore, more research is required to further assess the real impact 
of obesity onset on the CRF.  
 
4. Muscle strength 
The requirement of good CRF for optimal health maintenance has been well-
established28,72. In addition to CRF, muscle strength is also considered a critical element to 
sustain overall health and fitness and perform day-to-day activities73,74. Muscle strength is 
defined as a maximal, voluntary, isometric force. In other words, it is the ability to produce a 
force against a resistance75. Muscle strength is determined by neural, mechanical, and muscular 
factors76. It can be assessed as isometric (i.e. static) or isokinetic (i.e. dynamic) strength 77. For 
isometric measurements, handgrip dynamometers, and cable tensiometers are used. This type of 
measurement limits results to the muscle group and joint angle involved in testing. Despite the 
limitation of handgrip strength to a specific muscle group, the handgrip strength measurement 
has been shown to predict mortality and functional status of adult individuals78,79. A study by 
Ling et al80 found that there was an increase in risk for all-cause mortality (hazard ratio 1.06, CI 
1.01-1.12, p = 0.033) for each 5-kg decrease in handgrip strength. In another large cohort study 
by Ortega et al15, researchers followed more than one million adolescent participants for 24 years 
and found that participants with higher strength had 20-30% decrease in all cause mortality.  
 
4.1 Implications of obesity on muscle strength  
There are several perspectives on how obesity affects muscle strength. One view is that 
obesity can positively affect muscle strength as a consequence of increased effort to move their 
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additional body mass, especially in the lower body. This mimics a training effect81. Hulens et al82 
was one of the first to investigate the effect of obesity on muscle strength in adults and found that 
those with obesity have higher absolute strength in the lower body compared to normal weight 
subjects, whereas no differences were found in handgrip strength. The greater absolute knee 
extension and trunk extension strength were linked to the training effect of weight bearing in 
individuals with obesity. However, when all the strength results were adjusted for fat-free mass, 
the results were significantly lower for individuals with obesity (6 %)82. Other researchers have 
found that obesity is linked to reduced muscle strength, mass and quality83.  
Lower skeletal muscle strength in obesity may be caused by a number of factors. As 
obesity is associated with lower protein synthesis in skeletal muscle, this may result in a 
significantly reduced positive adaptation triggered from the weight bearing effects84. In addition, 
muscle strength has been observed to be negatively affected by intramuscular fat which is 
accumulated with increasing BMI/adiposity and has been associated with poorer muscle 
strength85. Furthermore, obesity is associated with impaired regulation of glucose metabolism 
and increased advanced glycation end-products in the blood. As muscle mass is the main site for 
glucose uptake, any impairment in glucose regulation might contribute to low muscle strength86. 
In addition, muscle stiffness and poorer physical function have been linked to increased 
advanced glycation end products. Individuals with obesity can encounter functional challenges in 
muscular performance as well postural balance limitations, reduce strength, and impaired 
mobility87,88.  
Only one study has investigated the effect of age of onset of obesity on muscle strength in 
older adults (> 55 years)89. They found that handgrip strength was lower in individuals who 
developed obesity as early as 20 years of age versus later in life. Furthermore, several studies 
have found that obesity negatively affects muscle strength in older adults90,91, young adults82,87 
and adolescents92,93, yet little is known about the specific muscle adaptations in individual who 
acquire adiposity early in life. 
 
5. Resting metabolic rate and substrate oxidation  
Total energy expenditure consists of three components: 1) resting metabolic rate (RMR), 
2) diet-induced thermogenesis, and 3) physical activity. RMR in sedentary individuals accounts 
for approximately 50-75% of their total energy expenditure94. RMR is defined by the amount of 
18 
 
energy required by an individual at rest95. Thus, measurement of RMR is fundamental in 
understanding the metabolism of an individual96. The relationship between RMR and body 
composition is a critical factor to consider when examining obesity97. RMR can be measured 
through indirect calorimetry which is a non-invasive technique based on the measurement of O2 
consumption and CO2 production. Accordingly, RMR can be estimated in the absence of a direct 
measurement of heat production98.   
Indirect calorimetry is based on several principles. One principle is that the oxidation of 
macronutrients reflects the O2 uptake and there is no substantial reservation of O2 in the body
99. 
Another principle is that all chemical energy created in the body comes from the oxidation of 
macronutrients: carbohydrate, fat, and protein. A third principle is that the ratio of O2  
consumption and CO2 production from oxidation of these substrates are fixed
99. By collecting the 
amount of oxygen consumption and carbon dioxide production, the calculation of RMR can be 
estimated using the Weir equation100.  
Several factors have been found to influence RMR. For example, studies have shown 
differences in RMR between men and women101,102. A study by Arciero et al101 found that 
absolute RMR was 23% lower in women (1,348 +/- 125 kcal/day) than in men (1,740 +/- 194 
kcal/day)101, and this result persisted after adjusting for FFM. Age also plays a role in RMR; 
young adults have higher RMRs than older adults (over 70 years of age). In addition, previous 
studies in adults have shown an age-related reduction in RMR103,104. This was also consistent in 
children as they have an inverse relationship between age and RMR105,106. A longitudinal study 
by Keys et al107 found that changes in body composition are a precursor to the decline in age-
related metabolic rate. However, it is still debatable whether these changes in the RMR are solely 
due to changes in body composition or active cellular mass108,109. 
The resting exchange ratio (RER) is calculated as the ratio of carbon dioxide production 
to oxygen consumption, and can provide information about which substrate (fat or carbohydrate) 
is being utilized as the main fuel110,111. Proteins contribute 5-15 % to energy production at rest as 
their main role is to build muscle tissue and organs and provide essential enzymes and 
hormones112. 
Several validated equations such as the Livesey&Elia equations113 have also been 
developed to quantify rates of substrate oxidation. Substrate oxidation is defined as the ability of 
the body to oxidize carbohydrate, fat, and protein at rest in the fasted state. Under normal 
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conditions, healthy individuals have the ability to utilize both fats and carbohydrates, and switch 
between them based on the availability of these substrates114. This ability can be defined as 
metabolic flexibility115. However, the impairment of substrate oxidation, through either a 
declining fat utilization rate or a shift toward glucose oxidation can be defined as metabolic 
inflexibility115. Furthermore, metabolic inflexibility has been observed in chronic conditions such 
as diabetes, insulin resistance, non-alcoholic fatty liver disease,and obesity116,117. In combination 
with RMR, RER and substrate oxidation rates can provide valuable information about an 
individual’s metabolism118. 
 
5.1 Implications of obesity on resting metabolic rate 
Metabolic variables like RMR is are highly dependent on body size. Fat-free mass (FFM) 
is the major contributor to RMR119,120 with some studies finding an additional contribution of fat 
mass (FM)121,122. Several studies found that RMR was significantly lower (360 kcal/d) in 
individuals with normal weight compared to individuals with obesity123-128; however, others 
found no differences129,130. These inconsistent findings may be because the comparison groups in 
the latter studies129,130 had similar amounts of FFM. Based on a review published in 2016 by 
Carneiro et al131 there a was positive association between RMR and higher weight125,128,132. In 
comparative studies between different obese classifications and normal weight, the largest 
difference was found between individuals with class III obesity and normal weight. Class III 
obese had (540 kcal/d) higher RMR than normal weight and individuals with class1 obese had 
(240 kcal/d) higer than normal weight individuals123,127,128. Moreover, another cohort study by 
Weijs and Vansant133 found a higher difference by 800 kcal/d (p<0.001) as they compare 
individual with a BMI>50 (RMR =2157 kcal/d) with non-obese individuals (RMR=1331 kcal/d). 
Hence, RMR is commonly expressed per body mass or FFM to allow the comparison between 
groups with difference body sizes(though statistical adjustment for body mass or FFM is more 
accurate). It has been shown that, RMR per body mass is lower in individuals with obesity if we 
compare those with obesity to those with normal weight134. However, it has been observed that  
if the two individuals with obesity and normal weight have identical FFM then RMR per FFM 
would be equal135. 
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The role of age of obesity onset on RMR, however, remains unclear. Only one study by 
Blair & Buskirk136 in 1987, examined the effect of time of obesity onset on RMR. They found 
that adult and child-onset did not differ. However, their study had a serious limitation as they 
conducted the RMR measurement for only 5-10 minutes. For an accurate measurement, 
researchers often eliminate the first 5-10 minutes to make sure participants are in a steady state 
and past the acclimatization phase137. 
 
5.2 Implications of obesity on substrate oxidation   
  Decreased fat oxidation has been associated with obesity138,139. In individuals with 
obesity, the capacity to mobilize fatty acids from adipose tissue for oxidation in skeletal muscle 
has been reported to be impaired140,141. There are several factors that can affect this abnormality  
such as the availability of fatty acids142, skeletal muscle characteristics, muscle glycolytic flux, 
and hormonal and neural abnormalities143. In addition, decreased activity of some enzymes 
involved in the process of fat utilization may also contribute to the reduction of fat oxidation in 
individuals with obesity144. Activity of carnitine palmitoyl transferase, citrate synthase, and 
cytochrome c oxidase were found in a study conducted by Simoneau et al144 to be significantly 
lower in skeletal muscle samples that were collected from individuals with obesity compared to 
individuals with normal weight. Their findings were remarkable as they proposed some 
deficiencies in important key regulatory stages of fat oxidation, for instance fat transfer into the 
mitochondria carnitine palmitoyl transferase, enzymes of the Krebs cycle and the electron 
transport chain144. These finding were supported by several other studies that found a reduction 
in carnitine palmitoyl transferase, citrate synthase, and cytochrome c oxidase in the skeletal 
muscle of individuals with obesity141,145,146. Besides the decline of the activity of theses enzymes, 
there are also abnormalities in mitochondria morphology in individuals with obesity. In a study 
by Kirkwood et al147, they found a reduced size of skeletal muscle mitochondria in individuals 
with obesity compared to lean individuals by 35%. The reduced size of skeletal muscle 
mitochondria can lead to fat accumulation which might be a direct or indirect factor in the 
impairment of fat oxidation148. Taking these alterations together may provide information on the 
underlying mechanisms of the impairment of fat oxidation in individuals with obesity. However, 
to our knowledge, no one has studied the effect of obesity onset on substrate oxidation.  
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6. Rationale  
Obesity, in general, is associated with unwanted consequences such as inflammation and 
increased metabolic disease risk149. Moreover, adults with obesity who dated their obesity to 
childhood have a greater risk of developing CVD and type 2 diabetes than those who were 
normal weight in childhood 5,150,151. Despite our understanding of the pathophysiology 
underpinning obesity, there is limited data to explain the long-term effects of obesity in the adult 
population. Childhood-onset obesity not only prolongs the duration of obesity, but is also 
associated with alterations in adipose tissue growth and function that has been hypothesized to 
lead to earlier presentation of cardiovascular, musculoskeletal and metabolic diseases10,11,150,152. 
However, the risk of mortality and morbidity has been found to be reduced by higher CRF in 
individuals with obesity12-14, and higher muscle strength has been found to reduce mortality by 
20-30%15. Hence, it is worth exploring whether there are differences in CRF, handgrip strength 
as well as resting metabolism between individuals with childhood-onset versus adult-onset 
obesity. An increased understanding of how the timing of obesity onset affects these parameters 
will shape our ability to create therapeutic programs for this growing sub-population and may 
even help prevent future diseases. 
 
7. Study objectives   
The objective of this study is to determine the effect of age of obesity onset (childhood 




We hypothesize that adults with obesity who developed obesity in childhood will have 
lower CRF compared to adults with obesity who developed obesity later in life. This is opposite 
to the finding of Rupp at el71, the only study to test this hypothesis, due to the study’s limitations 
mentioned above. 
We also hypothesize that adults with obesity who developed obesity in childhood will 
have lower handgrip strength, RMR, and fat oxidation compared to adults with obesity who 
developed obesity later in life. 
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 9. Methods  
 9.1 Study participants 
Adult volunteers (male and female) were recruited through radio, poster, newspaper and 
online advertisements. In total, we recruited 31 sedentary participants aged 25-40 years old with 
a BMI of 29.5-39.4 kg/m2.  Participants had either childhood-onset or adult-onset obesity. 
Childhood-onset obesity was defined as obesity acquired pre- or peri-puberty as previously 
described by Lakshman et al7. Adulthood-onset obesity was defined as obesity acquired after the 
age of 18. Participants were asked to provide pictures of themselves as children and adolescents 
to assess their onset of obesity. In addition, all participants answered questions using body rating 
scales to confirm their age of obesity onset. The Collins scale153 (Appendix A), consisting of 
seven pictures for boys and girls ranging from underweight to obese, was used to assess weight 
status during childhood and adolescence. The Stunkard body rating scale154 (Appendix A), 
containing nine different pictures of men and women ranging from very thin to very obese, was 
used to assess weight status during adulthood.  
Eligibility of candidates to participate in the study was initially assessed through a 
telephone screening questionnaire. Suitable candidates were then interviewed in person about 
their weight, medical history, and dietary habits and physical activity. Individuals with certain 
cardiovascular diseases (i.e. heart attack and stroke), cancer, chronic respiratory diseases (i.e. 
chronic obstructive pulmonary disease), diabetes, autoimmune disease, mental illnesses or eating 
disorders were excluded. Individuals with hypothyroidism were eligible if their thyroid 
stimulating hormone concentrations were stable for at least one year. In addition, pregnant or 
breastfeeding women and individuals who used nicotine-containing products were not eligible 
for this study. Selected participants provided written in formed consent (Appendix B) and 
completed the physical activity readiness questionnaire (PAR-Q) (Appendix C)155.  Resting 
blood pressure was measured using an electronic blood pressure monitor (AccutorrV). 
Participants had a fasted blood draw for measurement of serum lipid profile and plasma glucose 







9.2 Anthropometric and body composition assessments 
Participants had their height and weight recorded in light clothing without shoes. A fixed-
wall stadiometer (Seca 216, Seca Corp., Chino, CA) was used to measure height to the nearest 
0.1 cm. Weight was obtained to the nearest 0.1 kg using a calibrated scale (DIN 2, AmCells 
Corp, Vista, CA). BMI was calculated as weight (kg) divided by height-squared (m2). Also, a 
calibrated dual X-ray absorptiometry (DXA) scanner (GE Healthcare Lunar Prodigy Advance™) 
was used to measure total FM, FFM and LBM, as well as forearm LBM. 
  
9.3 Cardiorespiratory fitness  
Participants underwent a submaximal bike test using the YMCA protocol to estimate 
their VO2max
52. The test was divided into 2-4 stages, with each stage at least 3 minutes in 
duration. The test assumes a linear relationship between an individual’s heart rate and VO2max, 
which occurs when the heart rate is >110 beats/min77. Each participant pedaled on a stationary 
bike (150 kpm/min, 0.5 KP or 25 watts at 50 rpm) with a gradual increase in resistance based on 
his or her heart rate during the first stage (see Figure 2). 
 
Figure 2. YMCA bike test stages 
As shown in Figure 2, the heart rate response in Stage 1 determined the workload in 
Stage 2. After that, the workload increased by 25 watts in all subsequent stages until the 























participant reaches 85% of their age-predicted maximum heart rate (HRmax). Heart rate was 
recorded every minute. If the participant's heart rate varied by >5 beats between the last two 
minutes of each stage, an additional minute was added to that stage until heart rate for the last 
two minutes was within ±5 beats/minute. If the participant's heart rate did not plateau, or if the 
participant did not maintain cadence, the test was considered invalid. Blood pressure was taken 
and recorded between the 2nd and 3rd minute of each stage. Participants were then asked about 
their rating of perceived exertion156 before the end of each stage.  
The test is designed to have a minimum of three stages: a 0.5 KP warm-up stage, 
followed by two additional submaximal stages based on the heart’s response to the first stage. An 
optional fourth stage was added if the participant's heart rate did not exceed the required 110 
beats/min. The workloads and heart rate values calculated in the final two stages of the protocol 
were used to estimate VO2max. We used the following formula to calculate sub-maximal VO2 at 
second-last workload (SM1) and submaximal VO2 at last workload (SM2): [(workload in 
watts/weight in Kg) * 10.8] + 7.0. Next, we calculated the slope (b) by using a second formula: 
(SM2-SM1)/(HR2-HR1). Here, HR1= average of last two heart rates from the second-last stage, 
while HR2= average of last two heart rates from the last stage. Finally, we estimated VO2max 
(ml/kg/min) by using the following formula: VO2max (ml/kg/min) = SM2+[b(HRmax-HR2)]. 
 
9.4 Handgrip strength  
A hand dynamometer was used to assess handgrip strength. For this assessment, the 
participant holds the handgrip dynamometer in the hand to be tested, inline with the forearm at 
the level of the thigh slightly away from the body. The handle of the dynamometer was adjusted, 
if required, for the grip size in order for the participant to feel comfortable while squeezing. 
When ready the subject squeezed the dynamometer with maximum isometric effort, which is 
maintained for about 5 seconds. Encouragement was given to help participants achieve 
maximum effort. There are two trials for each hand and the highest scores of each trial was 
combined to quantify the overall strength of the participant.  
 
 9.5 Resting metabolic rate and substrate oxidation 
Participants arrived at the testing location at 0800 am fasted for at least 8 hours. Their 
height and weight were measured, after which subjects were required to lie supine on a bed in a 
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dark environment and remain there resting for 90 minutes. A calibrated indirect calorimetry 
system (Sable Systems International) was used to measure the volume of O2 uptake (VO2) and 
CO2 production (VCO2) simultaneously with a hood canopy. Participants were instructed to 
remain awake and still throughout the measurement for 35 minutes. The system was set to record 
the fractional amount of O2 and CO2, mixing chamber temperature, water vapour pressure, 
barometric pressure, subsample flow rate, and mass flow rate in a negative pressure design.  
Calculations 
The indirect calorimetry data were truncated by 10 min for acclimatization with the 
ventilated hood. Data (VO2 and VCO2) were then included in the calculation of substrate 
oxidation (CHOox) and lipid (FATox) according to the following formulae113: 
CHOox (g/min) = 4.59VCO2 (l/min) - 3.23VO2 (l/min)  
FATox (g/min) = -1.70VCO2 (l/min) + 1.70VO2 (l/min)  
 
 9.6 Statistical analysis  
Statistical software SPSS (version 22.0) was used to analyze the data. Differences in 
CRF, handgrip strength, RMR and substrate oxidation between childhood-onset and adult-onset 
obesity were assessed using an independent samples t-test. The two-group distributions were 
sufficiently normal for the purpose of conducting a t-test (i.e., skew < (2.0) and kurtosis < 
(9.0)157. Furthermore, the assumption for homogeneity of variances was tested and satisfied via 
Levene’s F test. Cohen’s d was calculated based on the t test value for a between subjects t test 
and the degrees of freedom using the following formula (2t /√(df)) with a value of 0.8 or higher 
indicating a large effect size based on Cohen’s (1992) guidelines158. We used a multiple linear 
regression to test the effect of age of onset of obesity on CRF, hand grip strength, RMR and 
substrate oxidation adjusting for age and sex, and where relevant, body composition. Also, we 










10.1 Characteristics of study participants 
There were 31 participants included in this study: 18 with adult-onset obesity and 13 with 
childhood-onset obesity (Table 1). The two groups were similar in mean age and sex distribution. 
Weight and body mass index were also similar between groups as was body composition. 
Percent body fat was 41.5 ± 6.4% in the adult-onset group and 43.7 ± 4.7% in the childhood-
onset group. Blood samples were taken and assessed from all participants and no differences 
were found in total high-density lipoprotein and low-density lipoprotein cholesterol, and 
triglyceride concentrations between groups. 
 
10.2 Handgrip strength and cardiorespiratory fitness 
Mean handgrip strength based on the highest value for both hands combined was 
significantly lower in adults with childhood-onset obesity versus adult-onset obesity (CO: 56 ± 
10 vs. AO: 72 ± 20 kg; p = 0.01) (Figure 4). This was also the case when handgrip strength was 
based on the best value from the dominant hand only (CO: 28 ± 6 vs. AO: 35 ± 10 kg; p = 0.02) 
(Table 2). Cohen’s d was estimated at 1.10, which is indicated a large effect size. These 
differences persisted when adjustments for forearm lean mass, age, and sex were made. Also, 
total grip strength and forearm lean mass were strongly correlated (r = 0.805, p <0.001). In 
addition, a multiple linear regression analysis (Table 4) showed that both age of obesity onset 
and total forearm lean mass were significant predictors for both total and dominant handgrip 
strength independent of age and sex.  
We found no differences in CRF between groups (CO: 32 ± 6  vs. AO: 31 ± 5 ml·kg-
1·min-1; p = 0.38) (Figure 5; Table 2) even when adjusting for age, sex (Table 5). Results were 
similar when expressing VO2max per LBM or FFM. In the multiple linear regression, sex was a 
predicter of CRF VO2max (ml·kg
-1·min-1) independent of age and obesity onset (Table 5). 
 
10.3 Resting metabolic rate & substrate oxidation results  
RMR was not significantly different (p = 0.66) between groups (Table 6). Resting rates of 
fat oxidation were lower (p = 0.04) in the childhood-onset group compared to the adult-onset 
group (CO: 51.07 ± 18.39 vs. AO: 67.55 ± 23.83 mg/min) (Figure 7). Results persisted when 
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expressing fat oxidation per body weight. In contrast, there were no differences (p = 0.18) in 
rates of resting carbohydrate oxidation between groups (Figure 8). The differences in fat 
oxidation and similarities in carbohydrate oxidation in childhood- and adult-onset obesity 



























Par-Q+ body scale  
questionnaires 
n = 31
YMCA bike test + handgrip 
strength
n = 31




Age < 25 or > 40 (n = 368)
BMI < 29.5 or > 39.4 (n = 866) 
Medical condition (n = 21)
Medication use (n = 51)
Smoking (n = 9)
Other ((n = 3)
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Table 1. Subject characteristics 
 








Parameters Adult-onset (n=18) Childhood-onset (n=13) p-value 
Age (Years) 30 ± 3 30 ± 3 0.79 
Sex n (%) Men   






Weight (kg) 95.4 ± 9.8 94.7 ± 11.9 0.87 
Height (cm) 171 ± 8 166 ± 5 0.10 
Body mass index (kg/m2) 32 ± 3 33 ± 3 0.22 
Body fat (%) 41.5 ± 6.4 43.7 ± 4.7 0.29 
Total fat mass (kg) 39.6 ± 7.6 41.3 ± 6.7 0.52 
Total lean mass (kg) 52.3 ± 7.4 50.0 ± 8.5 0.45 
Fat free mass (kg) 55.2 ± 7.7 52.8 ± 9.0 0.43 
Glucose (mmol/L)  4.76 ± 0.41 4.75 ± 0.58 0.99 
Total Cholesterol (mmol/L) 4.46 ± 0.97 4.50 ± 0.84 0.89 
High-density lipoprotein  (mmol/L) 1.17 ± 0.23 1.23 ± 0.23 0.56 
Low-density lipoprotein (mmol/L)  2.73 ± 0.81 2.73 ± 0.70 0.99 




Table 2. Cardiorespiratory fitness and grip strength 
 














Parameters Childhood-onset (n=13) Adult-onset (n=18) p-value Cohen’s d 
Predicted Vo2max (ml·min-1) 3.08 ± 0.80 3.02 ± 0.57 0.83 0.08 
Predicted Vo2max (ml·kg-1·min-1) 32 ± 6 31 ± 5 0.84 0.07 
Heart rate (rest) (bpm) 87 ± 16 85 ± 9 0.64 0.17 
Systolic (rest)bp (mmHg) 115 ± 13 114 ± 10 0.84 0.07 
Diastolic (rest) bp (mmHg) 76 ± 10 76 ± 7 0.91 0.04 
Heart rate (2 min recovery) (bpm) 125 ± 10 127 ± 7 0.51 0.28 
Systolic (2min recovery) (mmHg) 125 ± 13 138 ± 15 0.02 0.92 
Diastolic (2min recovery) (mmHg) 63 ± 13 65 ± 11 0.65 0.18 
Handgrip strength total (kg) 56 ± 10 72 ± 20 0.01 1.10 
Dominant hand grip strength (kg) 28 ± 6 35 ± 10 0.02 0.90 
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Table 3. Resting metabolic rate and substrate oxidation. 























Parameters             Childhood-onset (n= 13)    Adult-onset (n=18)     P-value Cohen’s d 
RMR (kcal • d-1) 1830 ± 321 1873 ± 216 0.66 0.18 
RER (VCO2 • VO2−1 ) 0.88 ± 0.41 0.85 ± 0.42 0.06 0.77 
Fat oxidation (mg• min-1) 51.07 ± 18.39 67.55 ± 23.83 0.04 1.09 




                                     Figure 4. Handgrip strength by obesity-onset. 







































Table 4. Pearson correlation between total hand grip strength, dominant handgrip strength and 
total forearm lean mass and dominant hand forearm lean mass. 
 
  
Model Handgrip strength Dominant hand S 
Total forearm lean mass (kg) r 0.80**  0.79** 
p-value      0.00           0.00 
Dominant forearm lean mass (kg) r  0.79**   0.78** 
p-value      0.00           0.001 
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Model  B (kg) 95% Confidence Interval p-value 
Intercept -18.076            (-67.612 , 31.460) 0.46 
Age (years) 0.499             ( -0.733 , 1.731) 0.41 
Sex (men vs. women) 1.397             (-12.921 , 15.715) 0.84 
Total forearm lean mass (kg)  30.614             (17.333  , 43.896) 0.00 





Figure 5. Cardiorespiratory fitness by obesity-onset. 





































































Model B(ml·kg-1·min-1) 95% Confidence Interval p-value 
Intercept 35.178 (15.709, 54.648) 0.00 
Age (years) 0.014 (-0.651, 0.679) 0.96 
Sex (men vs. women) -5.838 (-10.653, -1.022) 0.02 






                                    Figure 6. Resting metabolic rate by obesity-onset. 
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Model B ((kcal · d-1) 95% Confidence Interval p-value 
Intercept 1317.909 (512.544, 2123.273) 0.00 
Age (years) 25.5 (-2.048 ,52.973) 0.07 
Sex (men vs. women) -323.556 (-522.749, -124.364) 0.00 





Figure 7. Fat oxidation by obesity-onset. 






































































Model B (mg · min-1) 95% Confidence Interval p-value 
Intercept 39.05 (-39.17 ,117.29) 0.31 
Age (years) 1.01 (-1.65, 3.68) 0.44 
Sex (men vs. women) -3.28 (-22.63, 16.06) 0.73 









Figure 8. Carbohydrate oxidation by obesity-onset. 








































































Model B (mg · min-1) 95% Confidence Interval p-value 
Intercept 148.44 (-66.94, 363.83) 0.16 
Age (years) 2.205 (-5.15, 9.56) 0.54 
Sex (men vs. women) -52.57 (-105.84, 0.70) 0.05 





This study examines whether obesity onset in childhood versus adulthood affects handgrip 
strength, CRF, RMR and substrate oxidation. To our knowledge, we are the first to investigate 
the effect of obesity onset on substrate oxidation and handgrip strength in young adults. Our 
overall findings indicate that those with obesity onset during childhood have lower handgrip 
strength and fat oxidation compared to those with adult-onset obesity. Furthermore, we found no 
differences in CRF between the two groups, though the majority of individuals had a poor rating. 




11.1 Handgrip strength  
Muscle strength is known as an important aspect of fitness and overall health; several 
studies have shown that handgrip strength can predict morbidity and mortality15,79,159,160. 
However, we know little about the effect of obesity onset on handgrip strength. In our study, we 
observed that individuals with childhood-onset obesity had lower handgrip strength. More 
importantly, we found that both obesity-onset and forearm lean mass were predictors of handgrip 
strength independent of age and sex. This indicates that age of obesity onset could be an 
important factor in affecting muscle strength and quality in adulthood.  
The only other study to examine the effect of obesity onset on handgrip strength was 
conducted by Stenholm et al89. Their findings indicate that individuals with early-onset obesity 
have lower muscle strength compared to those with late-onset obesity. This is consistent with our 
findings. However, though our results are similar, it is important to note that our participants 
were considerably younger than those of Stenholm et al89. The average age in the Stenholm study 
was 67 years, which is considered an older adult. In addition, they defined early-onset obesity to 
describe people who were considered obese as early as 20 years of age; based on our definition, 
this is still acquiring obesity as adult. Also, it is well known that aging is often accompanied with 
sarcopenia and dynapenia, the loss of muscle mass and strength respectively161. As their 
participants were older adults, an important question therefore arises: are their results the effect 
of aging, obesity or both? Furthermore, the duration of obesity might play an important role in 
the transition of muscle fiber types from slow twitch to fast twitch, and in turn, affect muscle 
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strength and function (see review162). The Stenholm study also used BMI alone to classify 
obesity, an approach that has several limitations, such as not distinguishing between fat mass and 
muscle mass.  We were able to confirm our BMI definition of obesity with DXA.  Our findings 
are also unique in terms of the age groups and the definition of childhood-onset obesity used in 
the study.  
Our result suggests that the effect of obesity onset on muscle strength may have more to 
do with muscle function than mass as no difference in total or forearm LBM were found between 
the two-groups measured by DXA.  Several cohort and cross-sectional studies have associated 
declining grip strength with higher fasting insulin, which may indicate that poor muscle strength 
precedes the development of insulin resistance163-165. 
Other possible explanations for the poor strength in adults with childhood-onset obesity 
have been suggested, including the view that it is a consequence of having obesity-associated 
systemic inflammation and insulin resistance165-168.  Several studies have found that prolonged 
obesity is a risk factor for both insulin resistance and type 2 diabetes169-171 Other well-
documented factors such as increased fat mass and physical inactivity can lead to increased 
muscle fat infiltration resulting in decreased muscle quality, increased inflammation and insulin 
resistance172.  Though our groups had similar fat mass and physical activity levels, we do not 
know if they had differences in inter- and intra-muscular fat content.   
 
11.2 Cardiorespiratory fitness 
  It is well known that higher CRF can attenuate disease risk factors that accompany 
obesity173. In obese individuals, lower CRF has been observed compared to lean individual36,37. 
Thus far, only one study has investigated the effect of obesity onset on CRF. In 2016, Rupp et 
al71 found that individuals with childhood-onset obesity had higher CRF results than those with 
late onset obesity71. In our study, however, we found no difference between groups. The lack of 
agreement between the results of the two studies may be due to different factors. In Rupp’s 
study, the mean age of the early onset group was significantly younger than the mean age of the 
late onset group by 7 years. CRF has been shown to decrease with aging, and their results did not 
adjust for age174. Also, participant weight history was determined through self-report, which can 
be influenced by participant perceptions. No additional evidence was used to verify the 
participants’ age of obesity onset. In our study, both pictures, the Stunkard and Collin scales 
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were used to obtain more accurate weight histories. In addition, in Rupp et al71 there was a wide 
range of BMIs among participants (25- 40 kg/m2), and the BMI was significantly higher in the 
childhood-onset group. 
Another difference between the Rupp study and ours is that Rupp used a treadmill test, 
which is a weight-bearing test, while we used a YMCA bike test, which is a non-weight bearing 
test. As previously reported by Mattson et al33, during normal walking, obese individuals used 57 
% of their VO2max compared to individuals of normal weight, who used only 36% of their 
VO2max. This may explain why individuals with obesity found walking difficult, even at low 
intensity. Therefore, a non-weight-bearing test may be a more appropriate measure, especially 
for individuals with obesity. Combined with handgrip strength, our findings indicate that early 
adiposity, influences strength but not CRF. 
 
11.3 Resting metabolic rate  
  No difference in RMR was found between the two groups. This finding was consistent 
with a previous study by Blair & Elsworth136, which explored the effect of obesity onset on 
RMR. Our results expanded on the findings of this study, which had a small sample size and 
used a different protocol to measure RMR. They used a 5-10 minutes measurements period, 
whereas, we used a 35-minute period. This is a serious limitation in their protocol as continuous 
measurement of indirect calorimetry less than 30 minutes is considered an insufficient duration 
and might result in a failure to reach steady state (physiologically)175. The two groups showed no 
differences in term of their age, sex, body composition, and weight. Based on these and our 
findings, it appears that age of obesity onset is not as important of a factor in determining RMR 
relative to other more major factors, such as age, sex, and body composition, especially FFM as 
it is a more metabolically active tissue. As expected, FFM and RMR were highly correlated for 
all groups, which is consistent with other studies120.  
 
11.4 Substrate oxidation  
This is the first study to examine how age of obesity onset affects substrate oxidation. 
Though there were no differences in RMR between our two groups, rates of fat oxidation were 
27% lower in the childhood- than in the adult-onset obesity group. Furthermore, the childhood-
onset group had a 16.5 mg/min lower fat oxidation rate than the adult-onset group independent of 
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age and sex (Table 8). There may be different reasons for this finding, such as obesity associated 
with increased insulin, which could prevent the transfer of fat across the muscle membrane and 
/or the mitochondrial membranes176. It has been found that childhood obesity predicts insulin 
resistance in young adulthood177. The role of insulin is to not only promote fat storage by process 
called lipogenesis, but also to prevent the body from using fat as fuel in another process called 
lipolysis178. Though not measured in our study, it is possible that greater insulin resistance in our 
childhood onset group could contribute towards impairment of fat oxidation at rest as insulin 
resistance decreases the rate of fat utilization in skeletal muscle and increase the appearance of 
free fatty acids. This causes accumulation of intracellular fatty acid metabolites that inhibit the 
insulin signaling pathway179.  
Since RMR and CHO oxidation were not different between the groups, and fat oxidation 
was higher in the adult-onset group, this might suggest that proteins oxidation could be higher in 
the childhood-onset group. This suggestion should be a topic for a future research. 
 
12. Limitations 
We were not able to gather medically measured weight histories. However, we did ask 
the participants to provide childhood pictures and used Stunkard and Collins scales in order to 
determine age of obesity onset to partially overcome this limitation. These scales have been 
validated by Must et al180 to assess long term recall of body size. They observed high 
correlations (r = 0.70 - 0.75) between recalled body size and measured BMI at ages 10 and 15. 
Also, there was a lack of control in terms of individuals’ diet composition (fat and CHO) before 
the measurement, which has been found to have an effect on substrate oxidation. A study by 
Bisschop et al181, studied three different diet compositions for 11 days prior to each measurement 
ranging from no fat (0%) to moderate (42%) to high fat (83%).  When participants had a high fat 
diet (83%) as opposed to a mixed diet, the fat oxidation increased significantly (p <0.05) 
compared to other diets. However, in our study based on 24 h dietary recalls, the majority of our 
participants consumed a mixed diet. Also, it is worth noting that we did not calculate protein 
oxidation because of the minor role of protein as a fuel especially in the resting state and because 
most participant who are weight stable are in nitrogen balance. This still might lead to small 
error or overestimations of fuel from other substrates182. 
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Another limitation of the study is that we did not measure the participant’s insulin levels, 
so we are unsure if participants were insulin sensitive or insulin resistant. Even though our 
participants did not have diabetes and had normal fasting plasma glucose concentration, they 
could still have hyperinsulinemia which is often characteristic of insulin resistance183. Finally, 
we did not calculate the duration of obesity in our outcomes as that might has an effect in our 
outcomes. 
As this study is cross-sectional in nature, cause and effect could not be determined. 
However, it would only be possible to confirm this if we were able to follow participants from 
childhood to adulthood, which is outside the scope of this study. 
 
13. Strengths  
DXA is the gold standard for measuring body composition and was used to measure 
participant body fat percentage, FFM and lean mass. As we found similarities in body 
composition between the two groups, other mechanisms or factors, besides body composition, 
may explain the observed difference in strength and fat metabolism. Our groups were also 
similar in age, and our age range was fairly narrow. This strengthens our results, as we know that 
FFM and VO2max decline with aging. Also, we used indirect calorimetry, the gold standard to 
measure RMR and substrate oxidation, instead of relying on predictive equations. Several studies 
have shown that some equations may not be accurate or appropriate for metabolic rate prediction 
in certain body weight categories184. 
  
 Summary  
Findings from our study suggest that there are differences in metabolism and muscle 
strength between those who have had obesity from childhood and those who only developed 
obesity in adulthood. Though CRF was not affected by obesity onset, those who developed 
obesity in childhood had decreased muscle strength despite similar muscle mass, which might 
indicate poor muscle quality and function. Moreover, though RMR was similar between the 
groups, those who had obesity since childhood also had impaired fat oxidation.  This finding 
suggests that fat loss may be more difficult in these individuals as this might indicate a 




14. Future direction 
Further studies are necessary to investigate whether there are differences in inter-and 
intra-muscular fat in these individuals that may affect grip strength. It may be also worthwhile to 
investigate the effect of diet composition on substrate oxidation prior to indirect calorimetry 
measurement181. Finally, these findings require replication through studies of participants with 
both childhood- and adult-onset obesity that include medical and fitness histories to also identify 
the real effect of the duration of obesity. Furthermore, measurement of additional variables, such 
as insulin sensitivity and C-reactive protein would further our understanding of how the timing 
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Appendix A: Body Rating Scales 
 
Body Rating Chart 
Participants will be asked to report how their body status at 5 years old, 10 years old, puberty, 20 




















 Figure number 
 1 2 3 4 5 6 7 8 9 
Age 5 ☐ ☐ ☐ ☐ ☐ ☐ ☐   
Age 10 ☐ ☐ ☐ ☐ ☐ ☐ ☐   
Puberty (Age 
_____) 
☐ ☐ ☐ ☐ ☐ ☐ ☐ 
  
Age 20 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Currently (Age 
_____) 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
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Childhood Body Rating Scale: Collins153’ Figure Drawings  
Girls 
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INFORMATION AND CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
Study Title:  
Acute and Chronic Effects of Obesity  
 
Researcher:   
Sylvia Santosa, PhD  
Assistant Professor 
Department of Exercise Science 
 
Researcher’s Contact Information: 
Science Pavilion165.21 
Concordia University 
7141 Sherbrooke Street West 
Montreal, QC  H4B 1R6 
 




Source of funding for the study:  
Heart and Stroke Foundation of Canada 




You are being invited to participate in the research study mentioned above. This form provides 
information about what participating would mean. Please read it carefully before deciding if you 
want to participate or not. If there is anything you do not understand, or if you want more 




You have been invited to take part in a study on aging, fat tissue risk factors for disease, and 
weight loss.  By participating, you will help us to better understand whether weight loss changes 
disease risk differently depending on the age when a person becomes overweight.  
B.PROCEDURES 
 
Your involvement in the study will last about 6 months or shortly after you lose around 10% of 
your starting body weight. The description below provides a general outline of the study 
protocol. Please note that there may be times where assessments and sample collection (e.g. a 
blood draw) occur outside of the usual timeline for reasons such as scheduling conflicts. 
 
Screening 
Maximum of 2 visits of up to 1.5 hours each 
The screening process will determine whether you are eligible for the study and will provide 
information for designing your weight loss protocol.   
  
Information Session. You will meet with members of the research staff to discuss the study and 
have your questions answered.  If you agree to enter the study, you will sign the consent form 
and provide a picture and medical records of height and weight from childhood.  You will also 
be asked to review and sign a behavioural contract agreeing to do your best to engage fully in the 
research project.      
 
Interview and Health Assessment. You will be asked to arrive after an overnight fast (no food 
for at least 8 hours before visit; water only). You will be interviewed about your medical history, 
weight history and diet. The health assessment will include a fasted blood draw, urine collection, 
and measurement of blood pressure, heart rate, weight and height. Please note that the health 




Questionnaires.  You will be asked to complete questionnaires about your health, eating 
behaviour, and quality of life.  Please note that these questionnaires will be repeated during the 
post-weight loss stabilization period. 
 
 
Pre- and Post-Weight Loss Stabilization Periods  
At least 4 visits of 5-10 minutes each over 2 weeks 
You will be instructed to follow your usual diet to maintain a stable weight for 2 weeks both 
before and after the weight loss protocol. To ensure that you are weight stable, you will be 
weighed after fasting for at least 8 hours at least twice a week. You will also record your food 
intake for 3 days (2 weekdays and 1 weekend day).      
 
Weight Loss Protocol 
Several visits a week for approximately 5 months 
During this period you will lose weight by diet and exercise. You will be instructed on how to 
decrease the amount of calories you eat in your diet by 20 % and increase the number of calories 
you burn by 10 % through moderate intensity exercise. You will be required to keep a paper-
based record of your daily diet.  You will also be required to wear a small physical activity 
monitor, similar to a step counter, periodically throughout the study. All exercise will be 
performed on cardio equipment at the study site at a self-selected frequency (2-4 visits) that will 
meet your weekly target. In addition, your weight will be measured and your weight loss 
progress will be monitored on a weekly basis. Monthly educational or support group sessions 
will also be conducted. You will follow the weight loss protocol until you lose around 10 % of 
your starting body weight, which is estimated to take approximately 5 months.  
  
Assessments  
Approximately 3-4 morning visits per time point 
You will have assessments at the following 3 time points: 
(1) Towards the end/after pre-weight loss stabilization period 
(2) 12-weeks after starting weight loss protocol 
(3) Towards the end/after post-weight loss stabilization period 
 
The following assessments will be conducted at time points (1), (2) and (3): 
 




You will undergo a submaximal fitness test.  You will pedal on a stationary bike for 
approximately 15 minutes.  Throughout this time, the resistance will be gradually increased, and 
your heart rate and blood pressure will be periodically assessed.  
 
You will perform a shuttle run/walk test.  You will run/walk back and forth between two lines 
in time with an audio ‘beep’.  The period of time required to reach the line will get progressively 
shorter.  The test will end when you can no longer continue or when you do not reach the line 
before the ‘beep’ on 2 consecutive occasions.  
 
You will perform a handgrip test.  You will squeeze your fist for 10-15 seconds around a 
device that measures your strength.   The test will be repeated 3 times per hand with at least 30 
seconds rest between each test.     
 
Body Composition Assessment by Dual Energy X-ray Absorptiometry  (DEXA). For the DEXA 
scan you will be positioned on the table and be asked to lie still as the DEXA arm passes over 
you. Total scan time is usually about 15 minutes. 
 
Circumference Measurements. The circumferences of different parts of your body (e.g. waist, 
hip, chest, arm, thigh) will be measured with a measuring tape.   
 
Energy Expenditure Assessment by Indirect Calorimetry.  You will arrive after an overnight fast 
of at least 8 hours and will rest comfortably for 2 hours before the test. You will breathe 
normally under a clear, plastic canopy for around 30 minutes while lying down. This will allow 
us to measure the rate at which your body burns calories (your energy expenditure).  Information 
from this assessment will help us determine how many calories you need to maintain weight or 
to lose weight at a certain rate.     
 
Blood Draw. Your blood will be drawn after an overnight fast of at least 8 hours.    
 
 
The following assessments will be conducted at time points (1) and (3) only: 
 
Body Composition Assessment by Computed Tomography (CT). If you are female, a urine 
pregnancy test will be conducted prior to this test to ensure you are not pregnant. During this 
test, you will lie on a table that will be passed through a large, open circular tube. The CT 
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machine will take pictures of your abdomen. The scan takes approximately 5-10 minutes to 
complete. 
 
Arterial Measurement. The hardening of your arteries will be measured while you are resting 
using a pen-like pressure sensor that will be placed on your skin on top of your pulse at three 
sites (wrist, neck, and crease of the leg). 
 
Biopsies. You will be asked to arrive after an overnight fast (water only after midnight). You will 
also be asked to not consume caffeine or alcohol for at least 24 hours prior to this visit. 
Strenuous exercise should also be avoided for at least 24 hours before the procedure.  
 
Fat. A sample will be taken from the fat in your stomach and thigh region. The procedure 
involves cleaning the skin to remove any germs, numbing the skin by injecting a local anesthesia 
(to freeze the area) with a thin needle, making a small nick incision and then removing the fat 
just below the skin. To remove the fat, a small hollow tube attached to a syringe will be used to 
suction out a small amount of fat tissue underneath your skin. The procedure will not require 
stitches, as the incisions are small; the physician will simply place sterile tape to close the 
incision. After the biopsies are done, post-biopsy care will be explained and you will be provided 
with written instructions. 
 
Muscle. A sample will be taken from the muscle on the outside side of your thigh. The procedure 
involves cleaning the skin to remove any germs, numbing the skin by injecting a local anesthesia 
(to freeze the area) with a thin needle, and making a small incision. A needle (hollow tube) will 
be inserted to remove a small piece of muscle. The procedure will not require stitches, as the 
incisions are small; the physician will simply place sterile tape to close the incision. Firm 
pressure will be applied to the area for 10 minutes to prevent bruising. After the biopsy is done, 
post-biopsy care will be explained and you will be provided with written instructions. 
 
C. RISKS AND BENEFITS 
 
The risks involved in the research tests are considered to be minimal. The risks are listed below: 
 
Blood Draws. There is a risk of discomfort, pain, fainting, bruising or infection (rare) from the 
blood draw. The amount of blood drawn at each time point will vary. Total blood drawn 
throughout the study will not exceed 2 cups (~500 mL). It is recommended that you avoid taking 
aspirin 3 days before and after the blood draws, and that you don’t donate blood for up to 8 




Fat and Muscle Biopsies. The most common risks of fat and muscle biopsies include pain, a 
small dent or bump and bruising at the site where the sample was taken. The bruising may last 
one to two weeks. Less common risks of biopsies include bleeding, infection, a small scar, and 
numbness of the skin around the biopsy site. The chance of these risks is less than 1% (1 in 100). 
There is also a chance of an allergic reaction to the lidocaine used for local anaesthesia. Care will 
be taken to reduce the chances of these risks. Aspirin should be avoided 3 days before and after 
the biopsies. It is not advised to participate in any vigorous activities for 3 days before and after 
the biopsies.  Exposure to water for prolonged periods should be avoided (e.g bathtubs, hot tubs 
or swimming) for 5 days after the biopsies. Showering is permitted, however band-aids must be 
changed afterwards. Normal daily activities will not be affected.  
 
Indirect Calorimetry. There is a slight risk of discomfort and hyperventilation from 
claustrophobia when under the clear, plastic hood. Staff will be present and the hood is easily 
removable. 
    
DEXA and CT Scans. You will be exposed to some radiation with the DEXA and CT scan. 
The amount of radiation used is considered too low to cause any harmful side effects. Radiation 
exposure from the DEXA scan is similar to the amount you would receive from sun exposure on 
a sunny day (1/10th that of a chest x-ray). The amount of radiation you are exposed to from the 
CT scan is less than your exposure from one return transatlantic plane flight (about 2-3 chest x-
rays). The radiation does not remain in the body after the scan. Should you have any concerns, 
the research team will be happy to address them with you. 
 
Fitness Test and Exercise. You may experience some discomfort from physical exertion 
during the fitness test and the exercise component of the weight loss protocol.  
 
Your assessments will be supervised by experienced research staff who will make every effort to 
keep you comfortable during the study.  
 
Although the assessments conducted as part of this protocol are not expected to provide you with 
any direct benefits, the results will tell you more about your health and metabolism and you may 






We will gather the following information as part of this research: demographic information, 
contact information, and the results of all study procedures described above.   
 
We will not allow anyone to access the information, except people directly involved in 
conducting the research, and except as described in this form. We will only use the information 
for the purposes of the research described in this form. 
 
To verify that the research is being conducted properly, regulatory authorities such as Health 
Canada might examine the information gathered. By participating, you agree to let these 
authorities have access to the information.  
 
The information gathered will be coded. That means that the information will be identified by a 
code. The researcher will have a list that links the code to your name. 
 
All of your paper-based information will be kept in a filing cabinet in a secure and private 
research office.  All of your electronic information will be stored on a password-protected 
research computer.  The urine, blood, fat and muscle samples will be coded and safely stored for 
analyses at Concordia University. 
    
We intend to publish the results of the research. However, it will not be possible to identify you 
in the published results. 
 
 
E. BIOLOGICAL SAMPLES 
 
You will be asked to provide the following biological samples as part of the research: urine, 
blood, fat and muscle.  
 
Taking these specimens involves urinating into a plastic container, blood draws, and fat and 
muscle biopsies as described in the procedures section above.  
 
We will use your urine sample to assess your overall health with a standard urinalysis, and to do 
a pregnancy test for female participants.  We will use your blood samples to measure things like 
sugar, cholesterol and inflammatory markers.  We will use the biopsy samples to assess the 
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health of your fat and muscle.  This includes things like the size of your fat cells, the amount and 
type of inflammatory markers in your fat, and how well your muscle uses energy.       
 
We will keep the specimens for up to 25 years after the end of the study. After that, they will be 
destroyed. 
 
If we find anything that might be relevant to your health, we will contact you and direct you to 
the appropriate service.     
 
 
F.CONDITIONS OF PARTICIPATION 
 
You do not have to participate in this research. It is purely your decision. If you do participate, 
you can stop at any time. In addition, the research team may withdraw you from the study if you 
are not compliant.  
As a compensatory indemnity for participating in this research, you will receive $500. If you 
withdraw before the end of the research, you will receive an amount proportional to the time you 
spent in the study, as assessed by the research team. To make sure that research money is being 
spent properly, auditors from Concordia or outside will have access to a coded list of 
participants. It will not be possible to identify you from this list. 
 
We will tell you if we learn of anything that could affect your decision to stay in the research.  
 
There are no negative consequences for not participating, stopping in the middle, or asking us 
not to use your information.  
 
We will not be able to offer you compensation if you are injured in this research. However, you 
are not waiving any legal right to compensation by signing this form. 
 
G. PARTICIPANT’S DECLARATION 
 
I have read and understood this form. I have had the chance to ask questions and any questions 




NAME (please print) __________________________________________________________ 
 
SIGNATURE  _______________________________________________________________ 
 
DATE  _______________________________________________________________ 
 
If you have questions about the scientific or scholarly aspects of this research, please contact the 
researcher. Their contact information is on page 1.  
 
If you have concerns about ethical issues in this research, please contact the Manager, Research 
Ethics, Concordia University, 514.848.2424 ex. 7481 or oor.ethics@concordia.ca.  
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Appendix E: Normative table for Hand grip strength. 
 
 
